Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
PHASE2
RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells...
Status
Completed
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03
PHASE3
The investigators aimed to compare elective nodal irradiation versus involv...
Status
Unknown
Location
Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
PHASE2
This phase II trial studies how well cyclophosphamide works in preventing c...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
PHASE3
Currently, adjuvant therapy is not recommended for patients with esophageal...
Status
Recruiting
Location
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of Testis
PHASE2
This trial is a phase II non-comparative study aimed to determine the feasi...